Latest filing published 04 May 2022 for Silverback Therapeutics, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Valerie Odegard: trading record in brief
Valerie Odegard is a declared insider of ARS Pharmaceuticals, Inc. (chief executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 1 February 2022 to 2 May 2022, the count stands at 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 4 May 2022 came the latest disclosure, a share grant in ARS Pharmaceuticals, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Valerie Odegard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 45,233 shares0Common StockSEC:0001209191-22-027158:0
- 16,406 shares0Common StockSEC:0001209191-22-006434:0
2 of 2 declarations
